^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Endometrial Cancer |
| Drug: | capecitabine (Thymidylate synthase inhibitor) + mitomycin (DNA synthesis inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
09/20/2023
Excerpt:
Endometrial Carcinoma: SYSTEMIC THERAPY FOR ENDOMETRIAL CARCINOMA…Other Recommended Regimens…Capecitabine/mitomycin…
